National Guideline Clearinghouse | Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis.

full-text ►
National Guideline Clearinghouse | Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis.

July 8, 2013

Guideline Title

Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis.

 

Bibliographic Source(s)

National Institute for Health and Clinical Excellence (NICE). Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis. London (UK): National Institute for Health and Clinical Excellence (NICE); 2013 Mar. 62 p. (Technology appraisal guidance; no. 276).

 

Guideline Status

This is the current release of the guideline.